中央型肺癌新辅助免疫联合化疗后行机器人袖式重建术一例

Robotic sleeve lobectomy for central lung cancer after neoadjuvant immunochemotherapy

随着科技的进步,肿瘤免疫治疗取得前所未有的成就,部分无法手术或难以手术的中央型肺癌患者在免疫治疗后重现手术的机会。而机器人手术系统可为肺癌患者带来更微创的治疗方案,通过机器人辅助完成袖式重建术可最大程度地保证完整切除肿瘤、缩小切除范围和保留健康肺组织。本文介绍一例中央型肺癌患者接受免疫联合化疗后行机器人辅助袖式重建术,术后恢复顺利,术后9d出院,随访1年,ECOG评分为1级。

With the advancement of science and technology,tumor immunotherapy has made unprecedented achievements.Some of patients with central lung cancer who is inoperable or difficult to take operation has a chance to take radical resection after neoadjuvant immunotherapy now.The robot-assisted surgery system brings lung cancer patients a more minimally invasive approach,which can make tumor resection more complete,reduce the resection area and maximally preserve the heathy lung tissue.In this paper,a case of the patient with central lung cancer underwent robot-assisted sleeve lobectomy after neoadjuvant immunochemotherapy is reported.